Quantitative Systematic Strategies LLC Tg Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$41.61 - $54.3 $179,089 - $233,707	-4,304 Reduced 41.3%	6,117 $295,000
Q4 2020 Feb 09, 2021	SELL	$25.27 - $54.9 $88,546 - $192,369	-3,504 Reduced 25.16%	10,421 $542,000
Q3 2020 Nov 09, 2020	SELL	$18.49 - $27.24 $147,254 - $216,939	-7,964 Reduced 36.38%	13,925 $373,000
Q2 2020 Aug 04, 2020	BUY	$8.9 - $21.84 $194,812 - $478,055	21,889 New	21,889 $426,000
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $57,092 - $155,204	-11,086 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$12.5 - $15.0 $138,575 - $166,290	11,086 New	11,086 $146,000

371

85.5M

3.78M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.57B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.